-
Henan Lingrui to Acquire Yingu Pharma for RMB 704 Million
•
China’s Henan Lingrui Pharmaceutical Co., Ltd. (SHA: 600285) announced plans to acquire a 90% ownership stake in Yingu Pharmaceutical Co., Ltd. for a consideration of RMB 704 million (USD 97 million). The deal underscores Lingrui’s strategic expansion in the pharmaceutical sector, targeting Yingu’s innovative product portfolio. Yingu Pharma’s Innovative Nasal…
